This could explain recently published results showing that AMPs produced by probiotic strains of Lactobacillus acidophilus reduce symptoms of hospitalized patients with COVID-19 and improve antibody production against SARS-CoV-2 [60,61,63,64]. The gene discussed is ADSL; the disease is COVID-19.